New animal models for hepatitis C could pave the way for a vaccine

They say that an ounce of prevention is worth a pound of cure. In the case of hepatitis C—a disease that affects nearly 71 million people worldwide, causing cirrhosis and liver cancer if left untreated—it might be worth even more. The reason is that the disease shows no outward signs, and more than 80 percent of sufferers go undiagnosed. So while an effective cure does exist, what’s most needed is a vaccine that can prevent infection in the first place.

The Week in Review: March 10, 2017 – March 17, 2017

Friday, March 17, 2017 News Recap Top of the news this week is a report from Cheryl Reitz who has just embarked on another Outreach Road Trip to BC's rural, remote, and First Nations communities.  The report this week covers Lytton, Spences Bridge and Cache Creek. The report is very detailed and we have included a slide show. Rural/Remote/Indigenous Hepatitis C Outreach 2017 – Part 1 Other News: Will they ever learn? Many years ago several senior...

Indian scientists develop Hepatitis C vaccine

Bengaluru: A group of Indian scientists has developed a vaccine meant to treat Hepatitis C, a virus or infection that causes liver disease and inflammation of the liver.According to the report in Times of India, the team from the Indian Institute of Science (IISc), Bengaluru, has developed a vaccine for HCV genotype 3a.The scientists said the vaccine has shown promising results in preclinical studies and is customised for the Indian population.It is said t